Last reviewed · How we verify
Afluria Influenza Vaccine
Afluria Influenza Vaccine stimulates the body's immune system to produce antibodies against the influenza virus.
Afluria Influenza Vaccine stimulates the body's immune system to produce antibodies against the influenza virus. Used for Prevention of influenza disease caused by influenza A and B viruses in individuals 6 months of age and older..
At a glance
| Generic name | Afluria Influenza Vaccine |
|---|---|
| Also known as | Afluria |
| Sponsor | Seqirus |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | Phase 2 |
Mechanism of action
This vaccine works by introducing a small, harmless piece of the influenza virus to the body, which triggers an immune response and helps the body recognize and fight the virus in the future.
Approved indications
- Prevention of influenza disease caused by influenza A and B viruses in individuals 6 months of age and older.
Common side effects
- Pain, redness, swelling, or itching at the injection site
Key clinical trials
- Vaccine Responses in Patients With B Cell Malignancies (PHASE4)
- WU 345: Immune Responses to Adjuvanted and Non-adjuvanted Seasonal Influenza Vaccines in the Lymphoid Tissues. (EARLY_PHASE1)
- A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age (PHASE3)
- Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects. (PHASE2)
- National Vaccine Adverse Event Reporting Survey and Etiology
- Effect of Influenza Vaccination on IVF Outcomes - IVF (PHASE4)
- Afluria Pregnancy Registry
- Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Afluria Influenza Vaccine CI brief — competitive landscape report
- Afluria Influenza Vaccine updates RSS · CI watch RSS
- Seqirus portfolio CI